Join
Live feed
·
PRReleasevia Quantisnow
Nuvation Bio Inc. logo

Nuvation Bio Announces Acquisition of Japan Rights to Safusidenib from Daiichi Sankyo

ByQuantisnow·Wall Street's wire, on your screen.
NUVB· Nuvation Bio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NUVB (Nuvation Bio Inc.) and more on Quantisnow.